KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Common Equity: 2017-2024

Historic Common Equity for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $6.1 billion.

  • Elanco Animal Health's Common Equity rose 3.46% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year increase of 3.46%. This contributed to the annual value of $6.1 billion for FY2024, which is 2.04% down from last year.
  • Elanco Animal Health's Common Equity amounted to $6.1 billion in FY2024, which was down 2.04% from $6.2 billion recorded in FY2023.
  • In the past 5 years, Elanco Animal Health's Common Equity ranged from a high of $8.5 billion in FY2020 and a low of $6.1 billion during FY2024.
  • Its 3-year average for Common Equity is $6.5 billion, with a median of $6.2 billion in 2023.
  • Per our database at Business Quant, Elanco Animal Health's Common Equity spiked by 52.46% in 2020 and then decreased by 14.62% in 2023.
  • Over the past 5 years, Elanco Animal Health's Common Equity (Yearly) stood at $8.5 billion in 2020, then fell by 11.22% to $7.5 billion in 2021, then dropped by 2.92% to $7.3 billion in 2022, then dropped by 14.62% to $6.2 billion in 2023, then declined by 2.04% to $6.1 billion in 2024.